Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Advanced dose calculation algorithms in lung cancer radiotherapy: Implications for SBRT and locally advanced disease in deep inspiration breath hold

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. The stray magnetic fields in Magnetic Resonance Current Density Imaging (MRCDI)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. [OA023] Multiparametric MRI measurements of renal perfusion and oxygenation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The impact of technology on the changing practice of lung SBRT

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  2. Multimodal soft tissue markers for bridging high-resolution diagnostic imaging with therapeutic intervention

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

PURPOSE: Evaluating performance of modern dose calculation algorithms in SBRT and locally advanced lung cancer radiotherapy in free breathing (FB) and deep inspiration breath hold (DIBH).

METHODS: For 17 patients with early stage and 17 with locally advanced lung cancer, a plan in FB and in DIBH were generated with Anisotropic Analytical Algorithm (AAA). Plans for early stage were 3D-conformal SBRT, 45 Gy in 3 fractions, prescribed to 95% isodose covering 95% of PTV and aiming for 140% dose centrally in the tumour. Locally advanced plans were volumetric modulated arc therapy, 66 Gy in 33 fractions, prescribed to mean PTV dose. Calculation grid size was 1 mm for SBRT and 2.5 mm for locally advanced plans. All plans were recalculated with AcurosXB with same MU as in AAA, for comparison on target coverage and dose to risk organs.

RESULTS: Lung volume increased in DIBH, resulting in decreased lung density (6% for early and 13% for locally-advanced group). In SBRT, AAA overestimated mean and near-minimum PTV dose (p-values < 0.01) compared to AcurosXB, with largest impact in DIBH (differences of up to 11 Gy). These clinically relevant differences may be a combination of small targets and large dose gradients within the PTV. In locally advanced group, AAA overestimated mean GTV, CTV and PTV doses by median less than 0.8 Gy and near-minimum doses by median 0.4-2.7 Gy. No clinically meaningful difference was observed for lung and heart dose metrics between the algorithms, for both FB and DIBH.

CONCLUSIONS: AAA overestimated target coverage compared to AcurosXB, especially in DIBH for SBRT.

TidsskriftPhysica Medica
Sider (fra-til)50-57
Antal sider8
StatusUdgivet - dec. 2018

ID: 55866293